Biochemical and morphological studies on a case of systemic carnitine deficiency.

C. Cerri, G. Meola, G. Scarlato

Research output: Contribution to journalArticle

Abstract

The authors report a patient with systemic carnitine deficiency in which, despite restoration of normal serum carnitine level by therapy, the fatal course of the disease progressed. Postmortem studies of cardiac muscle with Oil red O failed to show lipid accumulation which was still present in muscle and liver. Carnitine level in liver was less than 10% of the controls values; total carnitine in muscle was 50% of the controls with differences in its esterification pattern; whereas the free carnitine was 1/10 of normal, the long chain esterified one was 3 times higher than the control. Heart carnitine content was normal. The authors suggest that although no therapeutic effects were detected in skeletal muscle, the normal carnitine content and the absence of lipidosis in the heart suggest that carnitine therapy may have been beneficial in our patient enabling the heart to utilize fatty acids.

Original languageEnglish
Pages (from-to)219-220
Number of pages2
JournalActa neuropathologica. Supplementum
Volume7
Publication statusPublished - 1981

Fingerprint

Carnitine
Lipidoses
Muscles
Esterification
Liver
Therapeutic Uses
Systemic carnitine deficiency
Myocardium
Skeletal Muscle
Fatty Acids
Lipids
Therapeutics
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Biochemical and morphological studies on a case of systemic carnitine deficiency. / Cerri, C.; Meola, G.; Scarlato, G.

In: Acta neuropathologica. Supplementum, Vol. 7, 1981, p. 219-220.

Research output: Contribution to journalArticle

@article{2ff22ad2a5da444a83fa50391c37eb88,
title = "Biochemical and morphological studies on a case of systemic carnitine deficiency.",
abstract = "The authors report a patient with systemic carnitine deficiency in which, despite restoration of normal serum carnitine level by therapy, the fatal course of the disease progressed. Postmortem studies of cardiac muscle with Oil red O failed to show lipid accumulation which was still present in muscle and liver. Carnitine level in liver was less than 10{\%} of the controls values; total carnitine in muscle was 50{\%} of the controls with differences in its esterification pattern; whereas the free carnitine was 1/10 of normal, the long chain esterified one was 3 times higher than the control. Heart carnitine content was normal. The authors suggest that although no therapeutic effects were detected in skeletal muscle, the normal carnitine content and the absence of lipidosis in the heart suggest that carnitine therapy may have been beneficial in our patient enabling the heart to utilize fatty acids.",
author = "C. Cerri and G. Meola and G. Scarlato",
year = "1981",
language = "English",
volume = "7",
pages = "219--220",
journal = "Acta neuropathologica. Supplementum",
issn = "0065-1435",

}

TY - JOUR

T1 - Biochemical and morphological studies on a case of systemic carnitine deficiency.

AU - Cerri, C.

AU - Meola, G.

AU - Scarlato, G.

PY - 1981

Y1 - 1981

N2 - The authors report a patient with systemic carnitine deficiency in which, despite restoration of normal serum carnitine level by therapy, the fatal course of the disease progressed. Postmortem studies of cardiac muscle with Oil red O failed to show lipid accumulation which was still present in muscle and liver. Carnitine level in liver was less than 10% of the controls values; total carnitine in muscle was 50% of the controls with differences in its esterification pattern; whereas the free carnitine was 1/10 of normal, the long chain esterified one was 3 times higher than the control. Heart carnitine content was normal. The authors suggest that although no therapeutic effects were detected in skeletal muscle, the normal carnitine content and the absence of lipidosis in the heart suggest that carnitine therapy may have been beneficial in our patient enabling the heart to utilize fatty acids.

AB - The authors report a patient with systemic carnitine deficiency in which, despite restoration of normal serum carnitine level by therapy, the fatal course of the disease progressed. Postmortem studies of cardiac muscle with Oil red O failed to show lipid accumulation which was still present in muscle and liver. Carnitine level in liver was less than 10% of the controls values; total carnitine in muscle was 50% of the controls with differences in its esterification pattern; whereas the free carnitine was 1/10 of normal, the long chain esterified one was 3 times higher than the control. Heart carnitine content was normal. The authors suggest that although no therapeutic effects were detected in skeletal muscle, the normal carnitine content and the absence of lipidosis in the heart suggest that carnitine therapy may have been beneficial in our patient enabling the heart to utilize fatty acids.

UR - http://www.scopus.com/inward/record.url?scp=0019399829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019399829&partnerID=8YFLogxK

M3 - Article

C2 - 6939239

AN - SCOPUS:0019399829

VL - 7

SP - 219

EP - 220

JO - Acta neuropathologica. Supplementum

JF - Acta neuropathologica. Supplementum

SN - 0065-1435

ER -